Dr Taieb on the FDA Approval of TAS-102 Plus Bevacizumab in mCRC | OncLive
Dr Taieb on the FDA Approval of TAS-102 Plus Bevacizumab in mCRC | OncLive
2023年8月2日
onclive.com
Dr Raghav on ABBV-400 Plus 5-FU, Folinic Acid, and Bevacizumab in Previously Treated mCRC | OncLive
Dr Raghav on ABBV-400 Plus 5-FU, Folinic Acid, and Bevacizumab in Previously Treated mCRC | OncLive
2025年1月31日
onclive.com
Capecitabine/Bevacizumab and Signs of Progression/Recurrence for mCRC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Capecitabine/Bevacizumab and Signs of Progression/Recurrence for mCRC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
2021年9月23日
targetedonc.com
Bevacizumab: Etkiler, Endikasyonlar, Yan Etkiler 💊 Bilimsel-Pratik Tıp Dergisi - 2025
Bevacizumab: Etkiler, Endikasyonlar, Yan Etkiler 💊 Bilimsel-Pratik Tıp Dergisi - 2025
2020年10月13日
the-health-site.com
How Tolerable is Pembrolizumab/Paclitaxel/Bevacizumab in PROC? | CancerNetwork
How Tolerable is Pembrolizumab/Paclitaxel/Bevacizumab in PROC? | CancerNetwork
2 个月之前
cancernetwork.com
Dr. Liu on the Use of Bevacizumab in Newly Diagnosed Advanced Ovarian Cancer | OncLive
Dr. Liu on the Use of Bevacizumab in Newly Diagnosed Advanced Ovarian Cancer | OncLive
2019年1月8日
onclive.com
The nurse is preparing to add a dose of bevacizumab (Avastin) t... | Filo
The nurse is preparing to add a dose of bevacizumab (Avastin) t... | Filo
已浏览 5136 次2025年4月14日
askfilo.com
Trifluridine/Tipiracil Plus Bevacizumab for Third-Line Treatment of Refractory Metastatic Colorectal Cancer: The Phase 3 Randomized SUNLIGHT Study | OncLive
2023年7月25日
onclive.com
Liệu pháp kháng sinh mạch Bevacizumab trong điều trị ung thư
2024年7月22日
vinmec.com
Dr. Tewari on Bevacizumab in Advanced Cervical Cancer | OncLive
2013年6月2日
onclive.com
Dr. Horn on the FDA Approval of Atezolizumab Plus Bevacizumab and Chemotherapy in NSCLC | OncLive
2018年12月7日
onclive.com
Dr Raghav on a Phase 2 Study of ABBV-400 Plus Fluorouracil, Folinic Acid, and Bevacizumab in Pretreated Metastatic CRC | OncLive
2025年1月26日
onclive.com
Dr. Gilbert on the Safety Profile of Mirvetuximab Soravtansine/Bevacizumab in Ovarian Cancer | OncLive
2020年7月16日
onclive.com
1:01
Dr Hardesty on Updated Data With Frontline Niraparib Plus Bevacizumab Maintenance in Advanced Ovarian Cancer | OncLive
2025年3月31日
onclive.com
FDA Approves Trifluridine/Tipiracil Plus Bevacizumab in Previously Treated Metastatic Colorectal Cancer | OncLive
2023年8月2日
onclive.com
Atezolizumab bevacizumab: la nuova pietra miliare nella terapia dell’epatocarcinoma - OncoInfo
2022年7月1日
oncoinfo.it
Henlius Fifth U.S. Filing Product Bevacizumab Biosimilar HLX04 Receives FDA BLA Acceptance
3 个月之前
marketscreener.com
Dr Taieb on the Safety Proline of TAS-102/Bevacizumab in Refractory mCRC | OncLive
2023年7月18日
onclive.com
4:13
Fatigue Associated with Bevacizumab, Fruquintinib, TAS-102 Therapies | OncLive
2024年3月21日
onclive.com
7:10
The STRIDE Regimen vs Atezolizumab/Bevacizumab: Selecting a Treatment Regimen in Unresectable HCC | OncLive
2024年10月25日
onclive.com
2:02
Dr Li on the Casdozokitug/Atezolizumab/Bevacizumab in Unresectable HCC | OncLive
2025年2月28日
onclive.com
Outlook Therapeutics, Inc.: Outlook Therapeutics Announces SMC Recommendation of LYTENAVA (bevacizumab gamma) for the Treatment of Wet AMD
11 个月之前
finanznachrichten.de
Considerations for Use of Bevacizumab-vikg in Wet AMD | AJMC
2022年3月16日
ajmc.com
Dr Finn on Tiragolumab Plus Atezolizumab and Bevacizumab in HCC | OncLive
9 个月之前
onclive.com
Sandoz, Bio-Thera Reach Deal On Biosimilar Bevacizumab For Treatment Of Multiple Types Of Cancers
2021年9月8日
nasdaq.com
Qu’est-ce que l’avastin (bévacizumab) contre le cancer ? | chimio-pratique.com
2017年2月26日
chimio-pratique.com
Treatments After Progression on FOLFOXIRI Bevacizumab
2021年3月18日
medscape.com
6:22
Cancer- Bevacizumab (Avastin) English
已浏览 221 次2020年7月17日
bilibilitggtgg
展开